Back to Search
Start Over
Researchers Submit Patent Application, "Common Cold Coronavirus T Cell Epitopes, Methods and Uses Thereof", for Approval (USPTO 20240294900).
- Source :
- Medical Letter on the CDC & FDA; 9/27/2024, p9455-9455, 1p
- Publication Year :
- 2024
-
Abstract
- A patent application has been submitted for the invention of T cell epitopes that provide broad protective immunity against multiple species of coronaviruses, including SARS-CoV-2. The invention involves peptides and proteins that can elicit a T cell response to the coronavirus and can be used in an immunogenic formulation with an adjuvant. This is significant in the context of the ongoing COVID-19 pandemic and the emergence of new variants. The patent application discusses a composition that can detect the presence of a coronavirus or an immune response related to coronavirus infections, vaccines, or therapies. It includes various amino acid sequences and can be formulated with adjuvants and modulators of immune response. The application also describes methods for detecting coronavirus-specific T cells and measuring their activity. For more information, please refer to the full patent application. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15324648
- Database :
- Supplemental Index
- Journal :
- Medical Letter on the CDC & FDA
- Publication Type :
- Periodical
- Accession number :
- 179747369